154
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Exposure and cancer risk assessment of polycyclic aromatic hydrocarbons (PAHs) in River Nile of Egypt

, & ORCID Icon
Pages 552-565 | Received 12 Aug 2021, Accepted 16 Dec 2021, Published online: 11 Jan 2022
 

ABSTRACT

Distributions of 16 PAHs in 50 samples collected from the Nile River in Egypt through 1 year were investigated to understand the carcinogenic risk. Determination of PAHs through the validated method with LOQ 0.01 µg/l, RC% ranged from 95% to 114%, RSD% ranged from ±4–9% using HPLC, and results showed that (∑PAHs) were ranged from 0.01 to 0.87 ±0.26 μg/L in which the highest in Giza and the dominant of PAHs was fluoranthene. Fifty per cent of the total analysed PAHs were from 4-rings and 5-rings PAHs. Toxicity was expressed by the presence of PAHs in terms of benzo(a)pyrene (BaP) concentration by establishing toxic, mutagenic equivalency factors (TEFs, MEFs) for PAHs. ΣTEQ and ΣMEQ for seven PAHs were 0.070 μg/L and 0.086 μg/L respectively. These compounds are considered traces, but exposure to it impacts mutagenic risk greater than carcinogenic risk. Incremental Lifetime Cancer Risk (ILCR) was 2*10−4 to 6*10−4 for adults and 2*10−4 to 7*10−4 for children, there is a chance for cancer risk except for ILCR of BaP 4*10−3 has no carcinogenic risk. Hazard Index (HI) <1, but we should not be ignored in the long-term our results provided useful information for decision-makers to control carcinogens PAHs and establish a standard national programme for permissible levels with treatment advanced technology.

Acknowledgments

The authors gratefully acknowledge the use of the facilities, equipment, and resources of the Holding Company for Water and Waste Water during the period of the development of this paper.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.